Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 25:27:100312.
doi: 10.1016/j.jctube.2022.100312. eCollection 2022 May.

Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda

Affiliations

Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda

Anthony Oriekot et al. J Clin Tuberc Other Mycobact Dis. .

Abstract

Background: Tuberculosis (TB) is one of the leading causes of death worldwide. Radiology has an important role in the diagnosis of both drug-sensitive (DS) and rifampicin-resistant (RR) pulmonary TB (PTB). This study aimed to compare the chest x-ray (CXR) patterns of microbiologically confirmed DS and RR PTB cases stratified by HIV serostatus in Uganda.

Methods: We conducted a hospital-based retrospective study at the Mulago National Referral Hospital (MNRH) TB wards. All participants had a microbiologically confirmed diagnosis of PTB. CXR findings extracted included infiltrates, consolidation, cavity, fibrosis, bronchiectasis, atelectasis, and other non-lung parenchymal findings. All films were examined by two independent radiologists blinded to the clinical diagnosis.

Results: We analyzed CXR findings of 165 participants: 139 DS- and 26 RR-TB cases. The majority (n = 118, 71.7%) of the participants were seronegative for HIV. Overall, 5/165 (3%) participants had normal CXR. There was no statistically significant difference in the proportion of participants with consolidations (74.8% versus 88.5%; p = 0.203), bronchopneumonic opacities (56.1% versus 42.3%, p = 0.207) and cavities (38.1% versus 46.2%, p = 0.514), across drug susceptibility status (DS versus RR TB). Among HIV-infected participants, consolidations were predominantly in the middle lung zone in the DS TB group and in the lower lung zone in the RR TB group (42.5% versus 12.8%, p = 0.66). HIV-infected participants with RR TB had statistically significantly larger cavity sizes compared to their HIV uninfected counterparts with RR TB (7.7 ± 6.8 cm versus 4.2 ± 1.3 cm, p = 0.004).

Conclusions: We observed that a vast majority of participants had similar CXR changes, irrespective of drug susceptibility status. However, HIV-infected RR PTB had larger cavities.The diagnostic utility of cavity sizes for the differentiation of HIV-infected and non-infected RR TB could be investigated further.

Keywords: Chest radiograph; DS-TB, Drug sensitive tuberculosis; Drug-sensitive; HIV, Human Immunodeficiency Virus; MDR, Multidrug resistant tuberculosis; MNRH, Mulago national referral hospital; MTB, Mycobacterium tuberculosis; PTB, Pulmonary Tuberculosis; Pulmonary tuberculosis; RIF, Resistance to rifampicin; RR-TB, Rifampicin-resistant tuberculosis; Rifampicin-resistant; WHO, World Health Organization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Frontal chest radiograph of HIV seronegative participants A) Of a 38 year old male patient with DS TB showing a consolidation involving the right upper and middle lung zones. B) Of a 26-year-old patient with DS TB showing consolidation in the right lower lung zone. C) Of a 26-year-old patient with a consolidation involving the left middle and lower lung zones. D) Of a 34 year old with DS TB showing multiple left upper lobe cavities, bronchopneumonic opacities in the whole left lung and right upper and middle lung zones. There are also bilateral areas of bronchiectasis.
Fig. 2
Fig. 2
Frontal chest radiograph of HIV seropositive participants A) Of a 39-year-old patient with DS TB showing multiple cavities in the left upper and middle lung zones and bronchopneumonic opacities involving the whole left lung field. B) Of a 42 year old patient with DS TB with bilateral upper lung zone cavities, bilateral upper and middle lung zone bronchiectasis and bilateral upper and middle lung zone bronchopneumonic opacities.

Similar articles

Cited by

References

    1. Fukunaga R., Glaziou P., Harris J.B., Date A., Floyd K., Kasaeva T. Epidemiology of tuberculosis and progress toward meeting global targets – worldwide, 2019. MMWR Morb Mortal Wkly Rep. 2021;70(12):427–430. - PMC - PubMed
    1. World Health Organization. Global tuberculosis report 2020: executive summary [Internet]. Geneva: World Health Organization; 2020 [cited 2022 Mar 19]. 11 p. Available from: https://apps.who.int/iris/handle/10665/337538.
    1. Ubaidi BAA, Ubaidi BAA. The Radiological Diagnosis of Pulmonary Tuberculosis (TB) in Primary Care. [cited 2021 Aug 22]; Available from: https://clinmedjournals.org/articles/jfmdp/journal-of-family-medicine-an....
    1. Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, et al. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PLoS One. 2011 Apr 29;6(4):e19399. - PMC - PubMed
    1. Icksan A.G., Napitupulu M.R.S., Nawas M.A., Nurwidya F. Chest X-ray findings comparison between multi-drug-resistant tuberculosis and drug-sensitive tuberculosis. J Nat Sci Biol Med. 2018;9(1):42–46. - PMC - PubMed

LinkOut - more resources